Find News

Filter articles

Applied Filters

Showing 781 to 790 of 910 results

Federal Circuit strikes down Apotex patent for inequitable conduct

US18-08-2014Legal developments

The US Court of Appeals for the Federal Circuit has affirmed a lower court’s ruling that an Apotex patent covering a method of making a drug is unenforceable due to inequitable conduct by the company’s founder and chairman Bernard Sherman.

Merck fined $1.8m for “anticompetitive” generic drug scheme


A Brazilian antitrust watchdog is fining German pharmaceutical company Merck $1.8 million for an alleged conspiracy to stop medicine distributors from working with generic drug makers.

Merck sues to block Cancidas generic

US11-08-2014Legal developments

New Jersey-based pharmaceutical company Merck has sued generic drug maker Fresenius for infringing patents relating to its anti-fungal injection Cancidas (caspofungin acetate).

Federal Circuit judges split on temazepam ‘sham’ case

US07-08-2014Legal developments

The US Court of Appeals for the Federal Circuit has affirmed a district court’s decision that pharmaceutical company Tyco’s patents directed to sleep aid drug temazepam were not infringed.

US District Court judge throws out Takeda’s case against Mylan

US06-08-2014Legal developments

US District Court for the Northern District of California judge Lucy Koh has dismissed Japanese pharmaceutical company Takeda’s patent infringement case against generic maker Mylan concerning acid reflux drug Dexilant (dexlansoprazole).

Akorn settles with FTC to allow VersaPharm merger

US05-08-2014Mergers & acquisitions

US-based injections maker Akorn has agreed to sell its rights to develop, manufacture and market generic tuberculosis injection rifampin to Watson Laboratories to settle charges by the US Federal Trade Commission (FTC) that its proposed acquisition of pharmaceutical company VersaPharm was likely to be anticompetitive.

AstraZeneca sues Zydus to protect Nexium

US04-08-2014Legal developments

Anglo-Swedish pharmaceutical company AstraZeneca has sued India-based Zydus for infringing three patents related to its heartburn drug Nexium (esomeprazole magnesium).

Boehringer sues Mylan over aspirin product


German pharmaceutical company Boehringer Ingelheim has sued generic drug maker Mylan for infringing a patent covering its Aggrenox drug.

Justice Arnold U-turns on Pharmacia case

UK28-07-2014Legal developments

Justice Arnold of the England and Wales High Court has decided to reverse a previous decision and grant Pfizer subsidiary Pharmacia its application to stay Actavis’s patent revocation action against it.

Dechert hires new life sciences partner


Law firm Dechert LLP has bolstered its life sciences team with the hire of Scott Warren as a partner in its IP practice in New York.

Showing 781 to 790 of 910 results